Literature DB >> 6744637

Proinsulin in human serum: problems in measurement and interpretation.

I P Gray, K Siddle, K Docherty, B H Frank, C N Hales.   

Abstract

The immunoreactivity of an extracted pancreatic human proinsulin standard in an indirect immunoradiometric assay was found to be at least one hundred times higher than that of biosynthetic human proinsulin. Limited tryptic digestion of the biosynthetic proinsulin increased its immunoreactivity in the assay and this was attributed to the production of partially cleaved proinsulin molecules which still retained the C-peptide moeity. This inference was confirmed by the finding that pure samples of 65/A1 and 32/33 split proinsulins reacted in the assay very similarly to the pancreatic proinsulin standard. The implications of these results are that the immunoassays of proinsulin using antisera to C-peptide may recognise the intact proinsulin molecule very poorly, if at all, and that the 'proinsulin' measured by such assays of human serum may be largely if not entirely intermediates of proinsulin cleavage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744637     DOI: 10.1111/j.1365-2265.1984.tb00134.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Immunological techniques in diabetes research: 14 years on.

Authors:  C N Hales
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  N Yoshioka; T Kuzuya; A Matsuda; M Taniguchi; Y Iwamoto
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

4.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

5.  Effects of octreotide on circulating islet B cell products in endogenous hyperinsulinism.

Authors:  A J Krentz; J Pace; W Somerville; P M Clark; M Nattrass
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

Review 6.  The pathogenesis of NIDDM.

Authors:  C N Hales
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  Differences in insulin sensitivity and secretory capacity based on OGTT in subjects with impaired glucose regulation.

Authors:  Sang Youl Rhee; Mi Kwang Kwon; Byong-Jo Park; Suk Chon; In-Kyung Jeong; Seungjoon Oh; Kyu Jeung Ahn; Ho Yeon Chung; Sung Woon Kim; Jin-Woo Kim; Young Seol Kim; Jeong-Taek Woo
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.